Statistical Models for Causation: What Inferential Leverage Do They Provide?
Freedman
Eval Rev 2006;30:691-713.
ABSTRACT
Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study
Majumdar et al.
BMJ 2006;333:999-999.
ABSTRACT
| FULL TEXT
Hormones and cardiovascular health in women
The ESHRE Capri Workshop Group
Hum Reprod Update 2006;12:483-497.
ABSTRACT
| FULL TEXT
Development and Validation of a Prognostic Index for 4-Year Mortality in Older Adults
Lee et al.
JAMA 2006;295:801-808.
ABSTRACT
| FULL TEXT
The Discrepancy between Observational Studies and Randomized Trials of Menopausal Hormone Therapy: Did Expectations Shape Experience?
Col and Pauker
ANN INTERN MED 2003;139:923-929.
ABSTRACT
| FULL TEXT
Evaluating Medication Effects Outside of Clinical Trials: New-User Designs
Ray
Am J Epidemiol 2003;158:915-920.
ABSTRACT
| FULL TEXT
Drug Therapy for Prevention of Recurrent Myocardial Infarction
van der Elst et al.
The Annals of Pharmacotherapy 2003;37:1465-1477.
ABSTRACT
| FULL TEXT
Lignes directrices de pratique clinique 2002 pour le diagnostic et le traitement de l'osteoporose au Canada
Brown and Josse
CMAJ 2003;168:SF1-38.
ABSTRACT
| FULL TEXT
Lipid-lowering agents and the risk of hip fracture in a Medicaid population
Ray et al.
Inj. Prev. 2002;8:276-279.
ABSTRACT
| FULL TEXT
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada
Brown and Josse
CMAJ 2002;167:s1-34.
ABSTRACT
| FULL TEXT
Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease
Humphrey et al.
ANN INTERN MED 2002;137:273-284.
ABSTRACT
| FULL TEXT
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease
Eckel et al.
Circulation 2002;105:2923-2928.
FULL TEXT
Overview of gender aspects of cardiac syndrome X
Kaski
Cardiovasc Res 2002;53:620-626.
ABSTRACT
| FULL TEXT
How Do Observational Studies Expand the Evidence Base for Therapy?
Radford and Foody
JAMA 2001;286:1228-1230.
FULL TEXT
Hormone Replacement Therapy and Cardiovascular Disease: A Statement for Healthcare Professionals From the American Heart Association
Mosca et al.
Circulation 2001;104:499-503.
FULL TEXT
The Heart and Estrogen/Progestin Replacement Study Revisited: Hormone Replacement Therapy Produced Net Harm, Consistent With the Observational Data
Blakely
Arch Intern Med 2000;160:2897-2900.
ABSTRACT
| FULL TEXT
Menopause and risk of non-fatal acute myocardial infarction: an Italian case-control study and a review of the literature
Fioretti et al.
Hum Reprod 2000;15:599-603.
ABSTRACT
| FULL TEXT
Gauging the Impact of Statins Using Number Needed to Treat
Kumana et al.
JAMA 1999;282:1899-1901.
FULL TEXT
Prescribing Hormone Replacement Therapy for Menopausal Symptoms
McNagny
ANN INTERN MED 1999;131:605-616.
ABSTRACT
| FULL TEXT
Hormone replacement therapy: a survey of Ontario physicians' prescribing practices
Elinson et al.
CMAJ 1999;161:695-698.
ABSTRACT
| FULL TEXT
Individually randomized intervention trials for disease prevention and control
Anderson and Prentice
Stat Methods Med Res 1999;8:287-309.
ABSTRACT
Hormone Replacement Therapy for Secondary Prevention of Coronary Heart Disease
Pan et al.
JAMA 1999;281:794-797.
FULL TEXT
Hormones and Vasoprotection
Oparil
Hypertension 1999;33:170-176.
ABSTRACT
| FULL TEXT
Editorial - Conversations with a Cab Driver
Rangaswamy
JBJS 1998;80:1407-9.
FULL TEXT
